icon-folder.gif   Conference Reports for NATAP  
 
  International Symposium on Viral Hepatitis and Liver Disease
March 20th - 24th 2009
Washington, DC		 Back grey_arrow_rt.gif
 
 
 
TMC435 HCV Protease Inhibitor Safety/antiviral activity
OPERA Study doses 25 & 75 mg once daily
 
 
  Reported by Jules Levin
ISVHLD Wash DC March 20-24 2009

TMC-1.gif

inHib-2.gif

non-3.gif

opera-4.gif

Ande-5.gif

HCV-6.gif

d3-7.gif

RNA-8.gif

LLD-9.gif

AE-10.gif